CXCL16 and neoplasm: CXCL16 combines with the chemokine CCL20 to engage innate and adaptive immune cells that participate in tumour immune initiation and response stages, enhance the overall antitumour immune response, and enhance therapeutic efficacy (Savage et al., 2023).